arrow
F

Fiona Blackhall

University of Manchester
H指数:89
被引数:4.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Seasonal variations in overall survival and vitamin D status in a UK pan-cancer cohort receiving checkpoint inhibitors

英国泛癌种队列接受免疫检查点抑制剂治疗患者的总体生存率及维生素D状态的季节性变化

2026-09-290
OAAI
Patient-reported outcomes with tarlatamab in extensive-stage small cell lung cancer after platinum-based chemotherapy: results from the phase 3 DeLLphi-304 trial

在铂类化疗后广泛期小细胞肺癌中使用塔拉他玛单抗的病人报告结局:DeLLphi-304 III期试验结果

2026-09-010
PRE
Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk prediction

纵向超敏ctDNA监测用于高分辨率肺癌风险预测

Cell
IF42.5
2025-11-070
OAAI
EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer

EORTC 1417 - REACTION:一项关于依托泊苷联合顺铂/卡铂,并联合或不联合帕博利珠单抗治疗初治广泛期小细胞肺癌的II期研究

2025-10-300
PRE
Matching-Adjusted Indirect Treatment Comparison of Tarlatamab Versus Comparator Therapies in England in Patients with Extensive-Stage Small Cell Lung Cancer Who Have Received Two or More Prior Lines of Therapy

基于匹配调整的间接治疗比较:英国广泛期小细胞肺癌患者中,接受两线或以上既往治疗的患者使用Tarlatamab与比较疗法的效果比较

2025-10-080
PRE
Consolidation thoracic radiotherapy after chemoimmunotherapy in ES-SCLC: A multicentric retrospective analysis

化疗免疫治疗后的小细胞肺癌的巩固性胸放射治疗:一项多中心回顾性分析

2025-06-250
PRE
Circulating Tumor Cells Shed Shearosome Extracellular Vesicles in Capillary Bifurcations That Activate Endothelial and Immune Cells

循环肿瘤细胞在毛细血管分叉处脱落剪切体细胞外囊泡,这些囊泡可激活内皮细胞和免疫细胞

2025-06-090
OAAI
Functional characterization of the ATOH1 molecular subtype indicates a pro-metastatic role in small cell lung cancer

ATOH1分子亚型的功能表征表明其在小细胞肺癌中具有促转移作用。

2025-05-010
PRE
Patient-Reported Outcomes for Patients with Previously Treated Small Cell Lung Cancer Receiving Tarlatamab: Results from the DeLLphi-301 Phase 2 Trial

先前接受过Tarlatamab治疗的小细胞肺癌患者的患者报告结局: DeLLphi-301 2期试验的结果

2025-03-010
OAAI
Hydroxychloroquine in combination with platinum doublet chemotherapy as first-line treatment for extensive-stage small cell lung cancer (Study 15): A randomised phase II multicentre trial☆

羟氯喹联合铂类双药化疗作为广泛期小细胞肺癌的一线治疗(研究15):一项随机II期多中心试验☆

2025-01-011
PRE
First-Line Chemo-Immunotherapy in SCLC: Outcomes of a Binational Real-World Study

SCLC的一线化学免疫疗法: 一项两国现实世界研究的结果

2025-01-010
OA
Plain language summary: tarlatamab for patients with previously treated small cell lung cancer
2024-11-120
OAAI
Efficacy of carboplatin-etoposide rechallenge after first-line chemo-immunotherapy in ES-SCLC: an international multicentric analysis
2024-09-190
OAAI